A new directed evolution method was used to enhance the thermostability of the wild-type GH11 xylanase 2 (known as BD-11) from Hypocrea jecorina (Trichoderma reesei). Both Look-Through Mutagenesis (LTM TM ), which is a method for rapidly screening selected positions in the protein sequence for amino acids that introduce favorable properties, and Combinatorial Beneficial Mutagenesis (CBM TM ), which is a method for identifying the best ensemble of individual mutations, were employed to enhance the stability of an enzyme that has been thoroughly engineered by various means during the past 20 years. A diverse set of novel mutations was discovered, including N71D, Y73G, T95G and Y96Q. When these mutations were combined into a single construct (Hjx-81), the purified protein was active even after heating at 1008 8 8 8 8C for 20 min. This time-effective method should be generally applicable for quickly improving the physicochemical properties of other industrial and therapeutic enzymes in only several months time.
Introduction
Enzymes are effective biocatalysts for chemical reactions in a wide variety of industrial, medical and food applications. Most natural enzymes, however, cannot survive the harsh environments encountered in many industrial processes and may not meet other criteria for successful and economical manufacturing on a large scale, limiting the medical and chemical products that could be produced enzymatically (Delagrave and Murphy, 2003; Turner, 2009) . Optimization projects typically seek catalytic activity that is longer acting, amenable to novel substrates, or more stable in a specific chemical environment (e.g., a new solvent) (Luetz et al., 2008) . Enzymes have been successfully improved by several rational and non-rational mutagenesis strategies, including random mutagenesis, site-specific mutagenesis and site-saturation mutagenesis (Winter et al., 1982; Oliphant and Struhl, 1989; Cunningham and Wells, 1989; Arnold, 1991, 1993; Delagrave et al., 1993; Stemmer, 1994; Short, 2001; Kaur and Sharma, 2006; Sen et al., 2007) . The challenge for protein engineering projects using these techniques is to find a strategy that effectively searches sequence space without creating libraries that are too large to screen.
We describe here the application of two mutagenesis platforms: Look-Through Mutagenesis (LTM TM ), a method for rapidly screening selected positions in the protein sequence for amino acids that introduce favorable properties, and Combinatorial Beneficial Mutagenesis (CBM TM ), which is a method for identifying the best ensemble of individual mutations. These techniques do not require high-throughput screening or special equipment and are designed to get the maximum information out of small, chemistry-driven libraries and to quickly identify informative leads.
For our proof-of-concept demonstration, we chose the enzyme xylanase (known as BD-11; endo-(1,4)-beta-xylan ase, EC 3.2.1.8) (Polizeli et al., 2005) from Hypocrea jecorina that cleaves the (1,4)-beta-D-xylosidic bonds in the xylan component of hemicellulose, which can eventually be converted into xylose. Xylanases are used in the paper industry, as well as to improve the nutrient availability of animal feed, to modify the consistency of dough for baking and to convert biomass into ethanol fuel (Beg et al., 2001; Subramaniyan and Prema, 2002; Bajpai, 2004) . Several rational and random mutagenesis strategies have been reported in the past to improve the thermostability of this industrially relevant enzyme (Cunningham and Wells, 1989; Arase et al., 1993; Short, 2001; Turunen et al., 2001; Turunen et al., 2002; Fenel et al., 2004; Palackal et al., 2004; Xiong et al., 2004; Sriprang et al., 2006; Stephens et al., 2007; Dumon et al., 2008; Ruller et al., 2008; Stephens, et al., 2009) . However, these strategies have relied heavily on structural data, which are not always available, or highthroughput robotics to effectively search the sequence space using random/saturation mutagenesis.
Another directed evolution method used to improve the thermostability of enzymes is iterative saturation mutagenesis (ISM). Iterative saturation mutagenesis uses repetitive cycles of saturation mutagenesis at rationally chosen sites of two or three amino acids of the protein and requires a protein structure. By limiting the mutagenesis to just a few amino acids and performing 3 -4 rounds of ISM on the mutants discovered during the screen, ISM leads to a fast convergence of beneficial mutations. These beneficial mutations are systematically incorporated into the libraries with each round of ISM (Reetz and Carballeira, 2007 (Jäckel and Hilvert, 2110) .
The LTM TM method is built on libraries that have sufficient diversity to generate positive initial hits while maintaining a manageable size for screening. Protein variants are created by direct and systematic introduction of a subset of amino acids that represent all the major side-chain chemistries and properties, such as size, shape, charge, hydrophobicity, hydrophilicity, etc. (G, S, H, L, P, Y, D, Q, K). The LTM TM method quickly generates information on the effects of specific chemistries at each residue position, along with identifying key residues that are crucial for protein structure and function. Despite the relatively small library size, which is highly beneficial for rapid screening, the libraries are nevertheless diverse enough to enable the discovery of rare mutants. In this way, the pitfall of the 'screening bottleneck' (and the concomitant inefficiency of screening large numbers of neutral and deleterious mutations) can be avoided. The LTM TM technology has previously been employed to improve the K D of the anti-TNF-a antibody D2E7 by 500-to 870-fold (Rajpal et al., 2005) .
After the initial positive variants have been identified, CBM TM libraries are then designed to combinatorially assemble the various beneficial mutations and look for synergistic improvements. The CBM TM library results in high-quality potential candidates, identifies immutable, structurally required positions in the protein, and drastically reduces library sizes, allowing the use of more advanced, but lower-throughput expression hosts. Our study employed Pichia pastoris, which has proven to be a robust expression system that secretes proteins into the culture media for easy use in an assay. It also allows for post-translational modifications, such as disulfide bonds and glycosylation (Cereghino and Cregg, 2000) , and has been previously used in xylanase expression studies (Damaso et al., 2003; He et al., 2009; Mchunu et al., 2009) . To further increase both cloning and screening efficiency in our directed evolution method, we have incorporated a pooling strategy, allowing simultaneous analysis of multiple samples followed by deconvolution. Pooling requires a sensitive assay with low background levels and mutants with significant increases in activity (Polizzi et al., 2005 (Polizzi et al., , 2006 . This pooling of mutants allows us to quickly scan and discover the regions of the entire protein where mutations have the maximum effect. It allows us to narrow down the number of mutation windows fairly quickly and only spend time deconvoluting the windows with the most promise. In this report we demonstrate that variants generated using the LTM TM /CBM TM approach are amenable to screening in pools of up to 63 mutants. We believe that this work represents a novel, resource-and time-efficient approach to protein engineering and will be easily adaptable to any number of industrial enzymes. Polymerase cycling assembly was performed as follows. All 16 oligos were mixed together at a concentration of 10 mM. The 50 ml assembly PCR 1 mixture contained 5 ml pooled oligos (10 mM), 10 ml of 5Â Buffer (Finnzymes), 1 ml of 10 mM dNTPs, 0.5 ml of Phusion Polymerase (Finnzymes) and 33.5 ml of H 2 O. The PCR protocol consisted of one cycle at 988C for 30 s, followed by 30 cycles at 988C for 7 s, 508C for 20 s and 728C for 15 s. The final cycle was 728C for 1 min.
Materials and methods

Reagents
The 100 ml rescue PCR mixture contained 2.5 ml of the PCR 1 reaction, 2.5 ml of Oligo 1, 2.5 ml of Oligo 16, 2 ml of 10 mM dNTPs, 20 ml of 5X Buffer (Finnzymes), 1 ml of Phusion Polymerase (Finnzymes) and 69.5 ml of diH 2 O. The PCR protocol was the same as the assembly reaction.
Polymerase chain reaction amplicons were purified using the Qiagen Qiaquick PCR Clean-up Kit (using the manufacturer's protocol), digested at 378C with the restriction enzymes EcoRI (NEB) and XbaI (NEB) and cloned into the P. pastoris plasmid, pPICZa C.
Genomic DNA isolation from P. pastoris
Yeast genomic DNA was recovered from 10 ml of P. pastoris culture by first spheroplasting the cells with zymolyase and then lysing them with 1% sodium dodecyl sulfate, followed by DNA precipitation. A detailed protocol and list of reagents can be found in the Invitrogen Pichia Expression Kit manual under the section entitled 'Total DNA Isolation from Pichia'.
DNA sequencing
Genomic DNA (1 mg/ml) and sequencing primers (20 mM) were submitted to Elim Biopharmaceuticals Inc. (Hayward, CA, USA) for sequencing using their fluorescent dideoxy terminator protocols. The sequencing primers were as follows:
P. pastoris expression
Ligation reactions were purified and concentrated by ethanol precipitation and then chemically transformed into the P. pastoris strain X-33 using the Pichia EasyComp Transformation Kit protocol. Positive transformants were selected on YPDS agar plates containing 100 mg/ml of zeocin. Transformants were picked and transferred into Buffered Minimal Glycerol (BMG) media for overnight growth. Cells were then resuspended at an OD 600 of 1 in buffered minimal methanol (BMM) for 48 h of expression. A detailed protocol for P. pastoris expression can be found in the Pichia Expression Kit manual from Invitrogen.
Thermostability assay
All of the xylanase variants were tested for thermostability in BMM media or, for His-tagged purified protein, in elution buffer (50 mM sodium phosphate, pH 8, 300 mM NaCl, 250 mM imidazole). The enzymes were heated for 20 min at 37, 50, 55, 60, 70, 80, 90 and 1008C in thin-wall PCR tubes and immediately cooled on ice. The sample tubes were heated in the heating block of an MJ Research Model PTC-200 thermocycler to control the temperature.
Xylanase activity assay
The Invitrogen EnzChek Ultra Xylanase Assay Kit was used to analyze the activity of the mutant libraries as well as the individual xylanase mutants. The assay was performed at pH 4.6 according to the manufacturer's instructions. Measurements were performed in a black, 96-well, flatbottom plate by adding 50 ml of heat-challenged xylanase enzyme and 2.5 mg of xylanase substrate in 50 ml of reaction buffer to a given well. The plate was then incubated at room temperature in the dark for 30 min. Relative fluorescence units (RFUs) were recorded using excitation at 360 nm and emission at 460 nm at 10-30 min intervals for up to 4 h.
CBM
TM library construction
Ten selected beneficial xylanase mutations for improved thermostability obtained through the LTM TM screens were used to combinatorially build a CBM TM library of 360 mutants by the use of degenerate oligonucleotides. The oligos were BD11_02E_6CBM1_A (ctctacaatataatattcaattaatgggttacggctccaacc GTA TAC ACT TAA AKR AGA ATY accattagggttgtaactacc), BD11_02E_6CBM2_A (ctctacaatataatattcaatta a-tgggttacggctccaacc GTA TAC ACT TAA ACC AGA ATY accattagggttgtaactacc), BD11_E_7_CBM1_S (attgaatattatattgtagag AAC TTT GGT RVT TMT AAC CCT tcaa c-aggtgctactaaatta) and BD-11_E_7_CBM2_S (attgaatattata ttgtagag AAC TTT GGT RVT SRA AAC CCT tcaacaggtgc tactaaatta). These oligos were designed to limit the number of non-consensus amino acids created by the degenerate oligos and were used to produce the CBM TM library by PCA -PCR. The library was sub-cloned into the pPICZaC plasmid, DNA was transformed into the P. pastoris X-33 strain and 600 clones were analyzed for activity at elevated temperatures.
Protein purification
Protein purification was preformed on 48 h supernatants as described in The Qiaexpressionist TM handbook from Qiagen using a 5 ml HisTrap FF crude column (GE Healthcare) and an Ä ktaprime FPLC unit.
Differential scanning fluorimetry
The hydrophilic fluorescent dye SYPRO Orange was added to the purified proteins in PBS buffer pH 7.4 and fluorescence was monitored using a real-time quantitative PCR thermal cycler (ABI PRISM w 7700 Sequence Detection System) as the temperature was increased in 1-degree increments. The reaction was set up as follows: 4 ml of purified xylanase at 50 mM in PBS pH 7.4 and 10 ml of SYPRO Orange 20X, 6 ml PBS pH 7.4. The thermocycler conditions were 258C, 0:15, auto-increment 18C, 60 cycles. The temperature at the midpoint of the resulting curve (T m ) was calculated using non-linear regression to fit a Boltzmann equation to the raw data with GraphPad PRISM w software.
Substrate specificity and kinetic parameters
The effects of the EnzChek xylanase substrate concentration on the xylanase activity of BD-11 and Hjx-81 were determined after a 5 min heat inactivation of the enzymes at increasing temperatures. BD-11 enzyme was heat inactivated at 558C for 5 min, while Hjx-81 was treated at 60-1008C for 5 min. These assays were performed in 1X reaction buffer (1 M sodium acetate, pH 4.6) at room temperature as previously described. The K m and V max values were calculated using substrate concentrations ranging from 5 to 0.1 mg/ml by plotting the Lineweaver2Burke diagram. The k cat value was determined by dividing the V max by the enzyme concentration.
Results
Screening pooled windows of xylanase variants for thermostability
A complete LTM TM scan of the entire xylanase sequence (190 amino acids) was performed using PCA. The xylanase gene was divided into 27 adjacent windows each containing seven amino acids: 14 ODD windows on one strand and 13 EVEN windows on the other strand. Fig. 1 outlines the oligonucleotide design and library construction scheme. Each window covers seven amino acid positions, which are individually mutated to one of the nine LTM TM amino acids (G, S, H, L, P, Y, D, Q or K) resulting in 27 libraries of 63 variants. Pooling into windows allows for a quick analysis of a seven amino acid block of the protein sequence with the LTM TM mutations. A high-temperature challenge inactivates all the enzymes that are unstable at the given combination of temperature and incubation time, making it is possible to find rare mutants within each library of 63 that are more thermostable.
The wild-type BD-11 enzyme expressed in P. pastoris shows minimal activity following a 558C, 20 min heat challenge in the Invitrogen EnzChek Ultra Xylanase Assay. The 27 libraries of LTM TM variants were tested in the xylanase assay after this modest, initial heat challenge. The results are shown in Fig. 2a , of the 27 libraries of 63 variants, 4 windows (ODD6, EVEN1, EVEN7 and EVEN12) showed improved xylanase activity when compared with the wild-type enzyme.
Engineering highly thermostable xylanase variants 
Deconvoluting the libraries to find individual beneficial mutations
We tested two deconvolution methods on these libraries. The first method was to reorganize the 63 mutants into 7 libraries of 9 mutants, so that each window would be resolved to single positions, each substituted with the nine LTM TM amino acids (Fig. 2b ). Window EVEN7 was tested in this manner and compared with window ODD7, which was used as a negative control, since it was not chosen as an active window during the initial screening of the pools of 63. Using this method, windows E7 -4, E7 -5 and E7 -6 showed improved xylanase activity after a 20 min challenge at 558C. The second approach was to clone and express all 63 individual mutants of windows ODD6 and EVEN7 immediately in P. pastoris and screen for improved thermostability at 558C (Fig. 2c and d) . Four beneficial mutations (N71D, Y73G, Y73S and Y73P) were found for ODD6 and six beneficial mutations (T95S, T95D, Y96Q, P98H, P98K and P98Q) were found for EVEN7 using this method. Both deconvolution methods were effective at finding individual mutations.
Combining individual mutations
A CBM TM matrix of the 10 beneficial mutations at positions 71, 73, 95, 96 and 98 was constructed with a diversity of 360 mutants (Fig. 3a) . The CBM TM library was expressed in TM library assayed over 4 h following treatment at room temperature and at 60-808C for 20 min. Wild-type BD-11 and culture medium was used as controls (note: the BD-11 control was only included to show that the BD-11 enzyme was active before thermal treatment. Without knowing the enzyme concentrations, no further conclusions can be drawn.) (b) Amino acid replacements found in sequence positions 71, 73, 95 and 96 in the various members (Nos. 19-91) of the CBM TM library that showed significant thermostability. Wild-type residues are listed in pink. Fig. 5 . Time course of xylanase activity in various dilutions of the purified Hjx-81 protein and in crude supernatant preparations after pretreatment at 1008C for 20 min. Supernatants were prepared and diluted directly from the yeast expression culture. The concentrated samples were purified on His-tagged columns and then diluted. The samples were diluted to check that activity is dependent on the concentration of the enzyme and also to reduce the concentration of the imidazole in the concentrated samples before assaying.
Engineering highly thermostable xylanase variants P. pastoris and 600 clones were analyzed for activity at elevated temperatures to ensure complete coverage of the library. Several variants displayed greatly increased activity (Fig. 4a) at temperatures up to 808C compared with wild-type enzyme and their sequences are shown in Fig. 4b . Interestingly, most of these variants have reduced activity at temperatures between 60 and 708C, followed by an increase in activity above 708C.
Characteristics of the best CBM
TM construct
Among the thermostable variants that were identified, clone Hjx-81 appeared to retain its activity over a wide range of temperatures (from 25 to 808C) when compared with the other clones. This clone had mutations at four positions (N71D, Y73G, T95G and Y96Q) compared with the wildtype BD-11 sequence (see Fig. 4b ). Hjx-81 was the only thermostable variant that had a glutamine with an amide side chain in amino acid position 96, possibly contributing to the better thermostability at 608C. In fact clone #53 differs from Hjx-81 only at position 96 and has five-fold lower activity at 608C. Hjx-81 was purified by metal-affinity chromatography and subjected to temperatures of up to 1008C. Although the activity of the engineered enzyme was partly destroyed at this high temperature, Hjx-81 in the supernatant still retained measurable activity after a 20 min 1008C challenge (Fig. 5) , reaching 60 000 Fluorescent Units in the EnzChek Ultra Xylanase assay in 2.5 h. We have also expressed Hjx-81 in Escherichia coli and have confirmed the increased activity of this clone at higher temperatures compared with the wildtype enzyme.
To examine the thermal stability of the xylanases, we used a thermofluor assay using the hydrophilic fluorescent dye SYPRO Orange and a real-time quantitative PCR thermal cycler (Uniewicz et al., 2010) . As shown in Table I , the T m value of the Hjx-81 xylanase shows a thermostability improvement of 78C when compared with wild-type BD-11 xylanase.
The enzymatic properties of BD-11 and Hjx-81 with no heat inactivation step are shown in Table II . The k cat for Hjx-81 is slightly higher than the k cat for BD-11, while the BD-11 enzyme (K m ¼ 2.7 mg ml 21 ) binds the substrate better than the Hjx-81 enzyme (K m ¼ 3.0 mg ml
21
). The ratio of k cat /K m, measuring the efficiency of an enzyme, for BD-11 drops by 50% after heating the enzyme for 5 min at 558C and by 87% when heated at 608C for 5 min. For Hjx-81, the enzyme k cat /K m value retained 69% of the enzyme efficiency after a 5 min 608C incubation. Hjx-81 shows its lowest k cat /K m ratio at 708C with an improvement of enzyme efficiency at the higher heat challenges. The k cat values show that the catalytic rate of Hjx-81 enzyme is much slower after heating to 708C and higher, but it still remains active. In the experimental data (Fig. 4a) , the BD-11 wildtype enzyme after a 20 min heat challenge of 608C and higher completely inactivates the enzyme, while for clone Hjx-81 the enzyme activity is significantly reduced but not inactivated after heating above 658C. Overall, the Hjx-81 enzyme still retains some activity at heat challenges up to 1008C.
Discussion
A great number of mutations have been introduced into various mesophilic and mildly thermophilic Family 11 xylanases in order to impart greater thermostability (reviewed in Hancock et al., 2006) . For example, Sriprang et al. (2006) used site-directed mutagenesis to improve the stability of Aspergillus niger BCC14405 xylanase after treatment at 508C, by replacing various Ser and Thr residues with Arg. Sung et al. (1998) introduced a portion of the N-terminal region of a thermophilic xylanase to improve the stability of T. reesei xylanase II. Wakarchuk et al. (1994) incorporated disulfide bonds into the xylanase from Bacillus circulans and thereby enhanced the thermostability.
Recently, Gene Site Saturation Mutagenesis (GSSM) and GeneReassembly technology have been employed to randomize successive codons in the xylanase XYL7746 from an environmental isolate (Palackal et al., 2004) . By screening 13 000 mutations, new enzyme variants were isolated whose thermostability exceeded 908C after a 5 min pretreatment. The most stable variant ('9X') contained a total of nine amino acid substitutions. A subsequent GSSM experiment by Dumon et al. (2008) employed the EvXyn11 xylanase and involved screening 70 000 colonies (representing 12 288 possible variants). A total of 15 of the most thermostabilizing mutations were sequenced and analyzed. A single, highly thermostable mutant, designated EvXyn11 TS , was then constructed which incorporated 7 of the 15 best mutations (S9P, T13F, N14H, Y18F, Q34L, S35E and S71T), and this clone retained 50% of catalytic activity after a 15-min incubation at 918C. For comparison, the most thermostable mutant produced in this work (designated Hjx-81) contains four amino acid substitutions and retains measurable activity even after a 20-min pretreatment at 1008C. Fig. 6 shows a comparison of the sequence positions that were The midpoint of thermal unfolding (T m ) was determined by differential scanning fluorimetry. The substrate used to measure the xylanase activity was provided in the Invitrogen EnzChek Ultra Xylanase Assay Kit. The enzymes were pre-incubated for 5 min at the given temperatures before the addition of substrate. The samples were run in triplicate.
mutated in the '9X' xylanase, the EvXyn11 and the BD-11 enzyme that is the subject of the present study. The mutations in Hjx-81 appear to be unique. The lack of overlap underscores the size of the sequence space that is available for enzyme improvement, even in a small protein that has been subjected to saturation mutagenesis. The EvXyn11 and XYL7746 saturation studies used libraries of nearly 13 000 variants and required automated robotics for screening rounds of 70 000 colonies and 40 000 colonies to find the individual and combinatorial mutations (Dumon, et al., 2008) . Using our chemistry-based system, our libraries are more manageable in size, since only 1600 variants were required for complete coverage of the BD-11 gene and the CBM TM library was comprised of only 360 variants. Owing to the lower number of variants in our libraries, more expression and screening options are available to us, such as P. pastoris, while gene saturation mutagenesis approaches use E. coli. Use of a eukaryotic expression host allows protein-engineering efforts to be conducted on proteins that may not be expressed in bacteria or that require post-translational modifications. Additionally, heterologous protein expressed in P. pastoris is secreted into the growth medium, greatly simplifying screening and subsequent isolation and purification of lead molecules. We specifically chose to use P. pastoris because it has previously been used to express xylanase (Damaso et al., 2003; He et al., 2009; Mchunu et al., 2009) and Pichia secretes sufficient quantities of xylanase protein into the media. Thus, during screening and deconvolution we can assay the media directly with no purification step.
By pooling the libraries into windows of 63 variants, our initial LTM TM of the entire BD-11 gene required assaying of only 27 libraries of 63 variants each. Windows displaying improved activity were re-cloned as seven libraries of nine variants each. Finally, the best pools of nine variants were assayed as individual variants. Using the pooling strategy allowed us to quickly identify regions of the protein that contribute to thermostability of the protein and to eliminate those portions that do not, greatly reducing the downstream screening workload. This workflow greatly reduces the resources required: this study was carried out in the span of 3 months by two full-time researchers without the aid of high-throughput robotics. Partial deconvolution and direct comparison of the positive window EVEN7 and a negative window ODD7 to seven sub-libraries of nine variants each demonstrates that the pooling strategy allows rapid homing in onto the positions that contribute to thermostability (EVEN7 -4, EVEN725 and EVEN726) without substantial false negatives. Two of the windows (ODD6 and EVEN7) were deconvoluted directly into the 63 individual library members and yielded similar results to the variants identified using the step-wise deconvolution approach. The reason why window ODD6 was chosen over windows EVEN1 and EVEN12 is that it was one of the first windows for which we had all 63 oligos in-house, and it was used to test the deconvolution method before analyzing all the other 25 windows. While we were deconvoluting the other positive windows, we started an initial CBM TM from the beneficial mutations of window ODD6 and EVEN7. We discovered clone Hjx-81 from this CBM TM library. Clone Hjx-81 was discovered from beneficial mutations in only two of the 27 windows of the BD-11 gene. Deconvolution of window EVEN1 could result in finding beneficial mutations in the N-terminal portion of the xylanase protein, as has been reported in other studies (Shibuya et al., 2000; Palackal et al., 2004; Dumon et al., 2008) . Window EVEN 12 has shown promise as another segment with beneficial mutations and it is closer to the C terminus of the protein than the other windows. Studies have shown that mutations both near and far from the active site of an enzyme can improve enzyme thermostability (Morley and Kazlauskas, 2005) . Thus, a second-generation Hjx-81 clone can be created with further improvements to thermostability and activity by building and screening a CBM TM library that (Törrönen and Rouvinen, 1995) are highlighted in orange.
Engineering highly thermostable xylanase variants incorporates combinations of the beneficial mutations from the other windows.
A closer look at the mutations assembled into clone Hjx-81 gives insight into the changes in amino acid properties that result in the improvement of xylanase thermostability. The first of the four beneficial mutations was N71D. Here the sizes of the two amino acids remain the same, but the mutation changes the amino acid from a neutral asparagine to an acidic amino acid. This change to a negatively charged aspartic acid would allow salt bridge formations with positive amino acids, creating hydrogen bonds and improving protein stability. The second mutation, Y73G, retains a hydrophobic side chain at amino acid 73, but the substitution of the glycine is a much smaller amino acid than tyrosine. The general trend of replacing the large phenolic side chains with smaller side chains in the thermostable mutants may suggest a possible reorientation of the substrate within the binding cleft. The third mutation, T95G, changes amino acid position 95 from a medium-sized hydrophilic amino acid to a smaller hydrophobic residue, thus altering protein structure. The last mutation, Y96Q, maintains a large-sized amino acid in position 96, but prefers an acyclic amino acid residue with no ring structure. Also, it changes a hydrophobic amino acid to a hydrophilic glutamine. Changing a hydrophobic amino acid to a hydrophilic amino acid and vice versa could affect protein folding and thus thermostability. The hydrophilic glutamine amino acid would allow hydrogen bonding between amino acids and thus may increase stability. In fact, Hjx-81 was the only enzyme from the CBM TM library that had this glutamine substitution at amino acid position 96 and was clearly the most thermostable enzyme. A clearer understanding of how the four mutations in Hjx-81 affect xylanase thermostability would require a complete molecular dynamics simulation study.
Most significantly, in the present study we were able to identify thermostable mutants of xylanase capable of enduring a 20 min challenge at 1008C by screening only 1600 variants and by reducing the 20 possible amino acids to a subset of only 9, which allows effective sampling of side chain chemistries without the need for large libraries. The Hjx-81 clone may be a suitable supplement for animal feed because of its improved thermostability over a wide range of temperatures, although further improvement of the enzyme reaction rate would be desirable. The LTM TM /CBM TM approach would allow small biotechnology companies and academic groups to effectively search sequence space and produce novel enzyme variants for any number of target reactions without considerable resources in manpower or robotics. Although this method requires an initial investment into the LTM TM mutagenesis oligonucleotides, the smaller library size greatly reduces the cost and time of screening.
The pooling approach employed here allows rapid screening of high numbers of variants in each sample, akin to pooling methods long employed in small-molecule discovery efforts. While it is conceivable that individual, modestly thermostable mutants may be masked by an overwhelming number of negative mutants in a given sample, no screening technology can completely sample the entire sequence space, even for an enzyme of only 190 amino acids. More often, researchers are faced with limited resources that necessitate some way to limit the number of variants. The LTM TM / CBM TM platform provides a chemistry-based approach to reducing sample size that we believe will be of tremendous value to protein engineering efforts.
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